303 related articles for article (PubMed ID: 26413810)
41. The role of the hedgehog signaling pathway in the development of basal cell carcinoma and opportunities for treatment.
Caro I; Low JA
Clin Cancer Res; 2010 Jul; 16(13):3335-9. PubMed ID: 20439455
[TBL] [Abstract][Full Text] [Related]
42. Further localization of the gene for nevoid basal cell carcinoma syndrome (NBCCS) in 15 Australasian families: linkage and loss of heterozygosity.
Chenevix-Trench G; Wicking C; Berkman J; Sharpe H; Hockey A; Haan E; Oley C; Ravine D; Turner A; Goldgar D
Am J Hum Genet; 1993 Sep; 53(3):760-7. PubMed ID: 8352281
[TBL] [Abstract][Full Text] [Related]
43. Myogenic tumors in nevoid Basal cell carcinoma syndrome.
Hettmer S; Teot LA; Kozakewich H; Werger AM; Davies KJ; Fletcher CD; Grier HE; Rodriguez-Galindo C; Wagers AJ
J Pediatr Hematol Oncol; 2015 Mar; 37(2):147-9. PubMed ID: 24517962
[TBL] [Abstract][Full Text] [Related]
44. Heterozygous PTCH1 Mutations Impact the Bone Metabolism in Patients With Nevoid Basal Cell Carcinoma Syndrome Likely by Regulating SPARC Expression.
Hong Y; Zhang J; Zhang H; Li X; Qu J; Zhai J; Zhang L; Chen F; Li T
J Bone Miner Res; 2016 Jul; 31(7):1413-28. PubMed ID: 26890308
[TBL] [Abstract][Full Text] [Related]
45. Treatment of multiple unresectable basal cell carcinomas from Gorlin-Goltz syndrome: a case report.
Ojevwe FO; Ojevwe CD; Zacny JP; Dudek AZ; Lin A; Kohlitz P
Anticancer Res; 2015 Mar; 35(3):1777-81. PubMed ID: 25750342
[TBL] [Abstract][Full Text] [Related]
46. Basal cell carcinoma pathogenesis and therapy involving hedgehog signaling and beyond.
Bakshi A; Chaudhary SC; Rana M; Elmets CA; Athar M
Mol Carcinog; 2017 Dec; 56(12):2543-2557. PubMed ID: 28574612
[TBL] [Abstract][Full Text] [Related]
47. Targeted exome sequencing and chromosomal microarray for the molecular diagnosis of nevoid basal cell carcinoma syndrome.
Matsudate Y; Naruto T; Hayashi Y; Minami M; Tohyama M; Yokota K; Yamada D; Imoto I; Kubo Y
J Dermatol Sci; 2017 Jun; 86(3):206-211. PubMed ID: 28342698
[TBL] [Abstract][Full Text] [Related]
48. Variable expression of Gorlin syndrome may reflect complexity of the signalling pathway.
Levanat S; Mubrin MK; Crnić I; Situm M; Basta-Juzbasić A
Pflugers Arch; 2000; 439(3 Suppl):R31-3. PubMed ID: 10653132
[TBL] [Abstract][Full Text] [Related]
49. FOXM1 is a downstream target of Gli1 in basal cell carcinomas.
Teh MT; Wong ST; Neill GW; Ghali LR; Philpott MP; Quinn AG
Cancer Res; 2002 Aug; 62(16):4773-80. PubMed ID: 12183437
[TBL] [Abstract][Full Text] [Related]
50. Hedgehog- and mTOR-targeted therapies for advanced basal cell carcinomas.
Piérard-Franchimont C; Hermanns-Lê T; Paquet P; Herfs M; Delvenne P; Piérard GE
Future Oncol; 2015 Nov; 11(22):2997-3002. PubMed ID: 26437034
[TBL] [Abstract][Full Text] [Related]
51. Ionizing Radiation Exposure and Basal Cell Carcinoma Pathogenesis.
Li C; Athar M
Radiat Res; 2016 Mar; 185(3):217-28. PubMed ID: 26930381
[TBL] [Abstract][Full Text] [Related]
52. Ptch1 overexpression drives skin carcinogenesis and developmental defects in K14Ptch(FVB) mice.
Kang HC; Wakabayashi Y; Jen KY; Mao JH; Zoumpourlis V; Del Rosario R; Balmain A
J Invest Dermatol; 2013 May; 133(5):1311-20. PubMed ID: 23223138
[TBL] [Abstract][Full Text] [Related]
53. [Skeletal and dermatological manifestations of the nevoid Basal cell carcinoma syndrome (Gorlin-Goltz syndrome). Results of 8 patients in 12 years].
Rupprecht M; Mensing CH; Barvencik F; Ittrich H; Heiland M; Rueger JM; Amling M; Pogoda P
Rofo; 2007 Jun; 179(6):618-26. PubMed ID: 17492539
[TBL] [Abstract][Full Text] [Related]
54. PTCH1 isoform 1b is the major transcript in the development of basal cell nevus syndrome.
Gielen RCAM; Reinders MGHC; Koillinen HK; Paulussen ADC; Mosterd K; van Geel M
J Hum Genet; 2018 Sep; 63(9):965-969. PubMed ID: 29930296
[TBL] [Abstract][Full Text] [Related]
55. A patient with neviod basal cell carcinoma syndrome treated successfully with photodynamic therapy: case report and review of the literature.
Schweiger ES; Kwasniak L; Tonkovic-Capin V
J Drugs Dermatol; 2010 Feb; 9(2):167-8. PubMed ID: 20214182
[TBL] [Abstract][Full Text] [Related]
56. Nevoid basal cell carcinoma syndrome. Report of a case with associated Hodgkin's disease.
Zvulunov A; Strother D; Zirbel G; Rabinowitz LG; Esterly NB
J Pediatr Hematol Oncol; 1995 Feb; 17(1):66-70. PubMed ID: 7743241
[TBL] [Abstract][Full Text] [Related]
57. Possibility of treating basal cell carcinomas of nevoid basal cell carcinoma syndrome with superficial x-ray therapy.
Caccialanza M; Percivalle S; Piccinno R
Dermatology; 2004; 208(1):60-3. PubMed ID: 14730239
[TBL] [Abstract][Full Text] [Related]
58. Clinical and genetic profiling of nevoid basal cell carcinoma syndrome in Korean patients by whole-exome sequencing.
Kim B; Kim MJ; Hur K; Jo SJ; Ko JM; Park SS; Seong MW; Mun JH
Sci Rep; 2021 Jan; 11(1):1163. PubMed ID: 33441926
[TBL] [Abstract][Full Text] [Related]
59. Sustained Hedgehog signaling is required for basal cell carcinoma proliferation and survival: conditional skin tumorigenesis recapitulates the hair growth cycle.
Hutchin ME; Kariapper MS; Grachtchouk M; Wang A; Wei L; Cummings D; Liu J; Michael LE; Glick A; Dlugosz AA
Genes Dev; 2005 Jan; 19(2):214-23. PubMed ID: 15625189
[TBL] [Abstract][Full Text] [Related]
60. Pharmacologic retinoid signaling and physiologic retinoic acid receptor signaling inhibit basal cell carcinoma tumorigenesis.
So PL; Fujimoto MA; Epstein EH
Mol Cancer Ther; 2008 May; 7(5):1275-84. PubMed ID: 18483315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
